• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,748.38 481.04
( 0.65%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
66,649.95 -284.38
(-0.42%)
Nikkei 225
10,313.41 -95.87
(-0.92%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Enbee Trade & Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
512441
INE993I01029
1.1513695
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
7.33
77.98
EPS(TTM)
Face Value()
Div & Yield %
0.06
1
0
 

Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries consolidated net profit rises 26.24% in the March 2026 quarter
May 22,2026
Net profit of Sun Pharmaceutical Industries rose 26.24% to Rs 2714.03 crore in the quarter ended March 2026 as against Rs 2149.88 crore during the previous quarter ended March 2025. Sales rose 13.61% to Rs 14559.75 crore in the quarter ended March 2026 as against Rs 12815.58 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.04% to Rs 11479.42 crore in the year ended March 2026 as against Rs 10929.04 crore during the previous year ended March 2025. Sales rose 11.87% to Rs 58220.11 crore in the year ended March 2026 as against Rs 52041.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales14559.7512815.58 14 58220.1152041.25 12
OPM %27.1629.00 -30.4629.35 -
PBDT4326.814279.82 1 19364.2117005.37 14
PBT3551.343616.03 -2 16426.3614429.98 14
NP2714.032149.88 26 11479.4210929.04 5